DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Lotan, Yair
Shah, Jay B.
Krishna, Viswesh
Launer, Bryn
Krishna, Vrishab
Shingi, Siddhant
Gordetsky, Jennifer
Gerald, Thomas
Shkolyar, Eugene
Hayne, Dickon
Redfern, Andrew
Spalding, Lisa
Stewart, Courtney
Narayanan, Vikram
Patil, Dattatreya
Packiam, Vignesh T.
Rajan, Anand
O'Donnell, Michael A.
Baekelandt, Loic
Fernandez, Mario I.
Schultz, Marcela
Hensley, Patrick J.
Allison, Derek B.
Taylor, John A.
Hamza, Ameer
Nimgaonkar, Vivek
Tiu, Ekin
Vaickus, Louis J.
Sonawane, Snehal
Miller, Daniel L.
Vrabac, Damir
Abuzeid, Waleed M.
Joshi, Anirudh
Chang, Sam S.
Williams, Stephen B.
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD27-12
引用
收藏
页码：E555 / E556
页数：2
相关论文
共 50 条
  • [41] Hyperthermic intravesical chemotherapy for BCG unresponsive or BCG ineligible non-muscle invasive bladder cancer
    de Jong, Joep J.
    Rosier, Marloes
    Boormans, Joost L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 613 - 613
  • [42] BLADDER SPARING TREATMENT IN PATIENTS WITH BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: AN ANALYSIS OF LONG-TERM SURVIVAL OUTCOMES
    Tan, Wei Shen
    Grajales, Valentina
    Contieri, Roberto
    Hensley, Patrick
    Bree, Kelly
    Msaouel, Pavlos
    Guo, Charles
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish
    JOURNAL OF UROLOGY, 2023, 209 : E410 - E410
  • [43] Editorial Comment to Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated disease
    Goto, Yusuke
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (11) : 957 - 958
  • [44] Impulsive control dosing BCG immunotherapy for non-muscle invasive bladder cancer
    Saadi S.
    Elmouki I.
    Hamdache A.
    International Journal of Dynamics and Control, 2015, 3 (3) : 313 - 323
  • [45] Current advances in BCG-unresponsive non-muscle invasive bladder cancer
    Tse, Jennifer
    Singla, Nirmish
    Ghandour, Rashed
    Lotan, Yair
    Margulis, Vitaly
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 757 - 770
  • [46] BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
    Guerrero-Ramos, F.
    ACTAS UROLOGICAS ESPANOLAS, 2023, 47 (06): : 329 - 331
  • [47] TUMOR MICROBIOME ASSOCIATED WITH BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER
    Knorr, Jacob
    Adler, Ava
    Agudelo, Jose
    Ericson, Kyle
    Murthy, Prithvi
    Campbell, Rebecca
    Bajic, Petar
    Almassi, Nima
    Weight, Christopher
    Haber, Georges-Pascal
    Miller, Aaron
    Lee, Byron
    JOURNAL OF UROLOGY, 2021, 206 : E725 - E726
  • [48] Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer
    Smaldone, M. C.
    Gingrich, J. R.
    MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (02) : 129 - 132
  • [49] Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)
    Alvarez-Maestro, M.
    Guerrero-Ramos, F.
    Rodriguez-Faba, O.
    Dominguez-Escrig, J. L.
    Fernandez-Gomez, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (02): : 93 - 102
  • [50] The current role of circulating biomarkers in non-muscle invasive bladder cancer
    Rink, Michael
    Schwarzenbach, Heidi
    Vetterlein, Malte W.
    Riethdorf, Sabine
    Soave, Armin
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 61 - 75
12345